American Journal of BioMedicine Volume 2, Issue 8, pages 1038-1049 September 2014
Jack B. Smith; Enza Hijiya; Kimberly Kumar; David Uleri; Armond Gresnigt
Abstract
The objective of the study is to evaluate the expression of Toll-like receptor-4 (TLR-4) in neonate infected by neonatal meningitis. Thirty neonate under the age 30 days with the clinical suspicion of neonatal meningitis were enrolled in the study. CSF and Nasopharyngeal secretions were obtained for laboratory testing, and blood samples were obtained for flow cytometry and cytokine level analysis. The mean fluorescence index, used as a measure of TLR-4 expression by monocytes, was significantly higher with neonatal meningitis than in the control group neonate (51.26 ± 29.41 vs. 28.22 ± 12, respectively; P= 0.002). We concluded that TL4 expression by monocytes are higher in neonate with positive PCR results for neonatal meningitis.
Keywords: Neonatal meningitis; TLR-4; CSF; Cytokine
Limited Access HTML Full Text-PDF Feedback
References
1. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:317–28. [PubMed]
2. Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet 2007;370:1947–59. [PubMed]
3. Herbert HK, Lee AC, Chandran A, Rudan I, Baqui AH. Care seeking for neonatal illness in low- and middle-income countries: a systematic review. PLoS Med 2012;9:e1001183. [PubMed]
4. Stoll BJ, Hansen NI, Sánchez PJ, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817–26. [PubMed]
5. Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012;130:e8–15. [PubMed]
6. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006;118:137–144. [PubMed]
7. Gordon AL, English M, Tumaini Dzombo J, Karisa M, Newton CR. Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya. Trop Med Int Health 2005;10:1114–20. [PubMed]
8. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627–4634. [PubMed]
9. Bennet R, Bergdahl S, Eriksson M, Zetterström R. The outcome of neonatal septicemia during fifteen years. Acta Paediatr Scand 1989;78:40–3. [PubMed]
10. Forster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, Rohrmeister K, Hayde M, et. al. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 2005;58:121–124. [Abstract/Full-Text]
11. Glass HC, Bonifacio SL, Chau V, et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 2008;122:299–305. [PubMed]
12. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, et. al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002; 186:1522–1525. [PubMed]
13. Dembinski J, Behrendt D, Martini R, Heep A, Bartmann P. Modulation of pro- and anti-inflammatory cytokine production in very pre-term infants. Cytokine 2003; 21:200–206.
14. O'Neill LA. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003;3:396–403. [PubMed]
15. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007;109:1574–1583.
16. Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T. Distinct pathways of LPS-induced NF-kB activation and cytokine production in human myeloid and non-myeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 2004;103:2229. [PubMed]
17. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996;l4:407–414. [PubMed]
18. Xu Y, Slimani H, Fersching K, Mark E, Baumbusch T, et. al. Neisseria meningitidis-mediates proinflammatory responses in PMN: Crosstalk TLR-2/c-JunN-Terminal Kinase. American Journal of BioMedicine 2014;2(3): 350–363. [Abstract/Full-Text]
